The application of nanoparticles as advanced drug delivery systems in Attenuating COPD

The application of nanoparticles as advanced drug delivery systems in Attenuating COPD

Blog Article

Chronic Obstructive Pulmonary Disease (COPD) is a dilapidating condition which is characterized by inflammation, an excess in free radical generation and airway obstruction.Currently, the drugs commercially available for the management of COPD pose several limitations such as systemic adverse effects, including bone density loss and an increased risk of developing pneumonia.Moreover, another limitation includes the need for regular and frequent dosing regimens; which can affect the adherence to the therapy.Furthermore, these current treatments provide remtavares.com symptomatic relief; however, they cannot stop the progression of COPD.Comparatively, nanoparticles (NPs) provide great therapeutic cga 200 to cga 510 adapter potential to treat COPD due to their high specificity, biocompatibility, and higher bioavailability.

Furthermore, the NP-based drug delivery systems involve less frequent dosing requirements and in smaller doses which assist in minimizing side effects.In this review, the benefits and limitations of conventional therapies are explored, while providing an in-depth insight on advanced applications of NP-based systems in the treatment of COPD.